Literature DB >> 3292330

Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes.

B Charlton1, T E Mandel.   

Abstract

The identity of the cells responsible for beta-cell destruction in type I (insulin-dependent) diabetes is still uncertain. L3T4+ T-lymphocytes have a role in the initiation of insulitis and in damaging transplanted allogeneic islets in nonobese diabetic (NOD) mice. The role of L3T4+ T-lymphocytes in destruction of beta-cells of the NOD mouse was studied in cyclophosphamide (CY)-induced diabetic NOD mice with a rat anti-L3T4 monoclonal antibody (MoAb). After administration of CY, most untreated animals became diabetic, whereas all antibody-treated animals remained normoglycemic. Insulitis was still present in MoAb-treated animals, but immunocytochemical staining showed rat antibody blocking the L3T4 antigen on T-lymphocytes. This study provides further evidence that L3T4+ T-lymphocytes are critical to the process of beta-cell destruction in NOD mice. The means by which L3T4+ cells exert their effect remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292330     DOI: 10.2337/diab.37.8.1108

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Non-obese diabetic transgenic mouse.

Authors:  K Yamamura; T Miyazaki; M Uno; T Toyonaga; J Miyazaki
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.

Authors:  V Menard; H Jacobs; H S Jun; J W Yoon; S W Kim
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody.

Authors:  T W Kay; I L Campbell; L Oxbrow; L C Harrison
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

4.  The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse.

Authors:  V Ablamunits; D Elias; I R Cohen
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 5.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 6.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

7.  IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Authors:  H E Thomas; J L Parker; R D Schreiber; T W Kay
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

8.  Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice.

Authors:  Ji Hoon Jeong; Sun Hwa Kim; Minhyung Lee; Won Jong Kim; Tae Gwan Park; Kyung Soo Ko; Sung Wan Kim
Journal:  J Control Release       Date:  2010-01-18       Impact factor: 9.776

9.  Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4.

Authors:  Shengwu Ma; Yan Huang; ZiQin Yin; Rima Menassa; James E Brandle; Anthony M Jevnikar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-31       Impact factor: 11.205

10.  Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.

Authors:  T Taki; K Yokono; K Amano; N Hatamori; Y Hirao; Y Tominaga; S Maeda; M Kasuga
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.